Pac Premier
Giving Guide
You are here:  Home  >  Biotech  >  Current Article

Sienna Biopharmaceuticals’ struggles doomed company

By   /   Friday, December 20th, 2019  /   Comments Off on Sienna Biopharmaceuticals’ struggles doomed company

    Print       Email
The ranks of tri-county public companies thinned in December, with the exit of Sienna Biopharmaceuticals after a disappointing auction of its assets that garnered only $1.7 million for a firm that has raised hundreds of millions of dollars for dermatology drug research and development. The closure comes just as the Westlake Village company applied for…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Limoneira, Calavo both report earnings growth as produce industry continues recovery

Read More →